Mikhail Y. Fedyanin
Doct. Sci. (Medicine), Head of the Chemotherapy Department, Moscow Multidisciplinary Clinical Center “Kommunarka”; Senior Researcher at the Chemotherapy Department, N.N. Blokhin National Medical Research Center of Oncology; Head of the Department, Pirogov Russian National Research Medical University, ORCID: https://orcid.org/0000-0001-5615-7806
Статьи автора:
PATHWAY DIRECTED MECHANISMS OF ANTI-EGFR RESISTANCE IN COLORECTAL CANCER (REVIEW)
Background: Targeting the epidermal growth factor receptor (EGFR) with cetuximab or panitumumab (anti-EGFR MAb) has been historically reserved ...
